CD274 and gastric cancer: As postoperative chemotherapy is still the first-line treatment for GC patients, so we try to combine conventional chemotherapy with molecular subtyping and PD-L1 expression, which may help to select the patients who would benefit the most from chemotherapy and provide evidence for individualized treatment of patients with GC.